MA46539A - Structures et mécanisme pour la conception de glucocorticoïdes hautement puissants - Google Patents

Structures et mécanisme pour la conception de glucocorticoïdes hautement puissants

Info

Publication number
MA46539A
MA46539A MA046539A MA46539A MA46539A MA 46539 A MA46539 A MA 46539A MA 046539 A MA046539 A MA 046539A MA 46539 A MA46539 A MA 46539A MA 46539 A MA46539 A MA 46539A
Authority
MA
Morocco
Prior art keywords
glucocorticoids
structures
design
highly powerful
powerful
Prior art date
Application number
MA046539A
Other languages
English (en)
Inventor
Yuanzheng He
Huaqiang Eric Xu
Original Assignee
Van Andel Res Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Van Andel Res Institute filed Critical Van Andel Res Institute
Publication of MA46539A publication Critical patent/MA46539A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0042Nitrogen only
    • C07J71/0047Nitrogen only at position 2(3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA046539A 2016-10-14 2017-10-13 Structures et mécanisme pour la conception de glucocorticoïdes hautement puissants MA46539A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662408314P 2016-10-14 2016-10-14

Publications (1)

Publication Number Publication Date
MA46539A true MA46539A (fr) 2019-08-21

Family

ID=61906432

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046539A MA46539A (fr) 2016-10-14 2017-10-13 Structures et mécanisme pour la conception de glucocorticoïdes hautement puissants

Country Status (12)

Country Link
US (1) US10954265B2 (fr)
EP (1) EP3525870B1 (fr)
JP (2) JP7146750B2 (fr)
KR (1) KR102497070B1 (fr)
CN (1) CN110382033B (fr)
ES (1) ES2945983T3 (fr)
MA (1) MA46539A (fr)
PH (1) PH12019500801A1 (fr)
RU (1) RU2019111101A (fr)
SG (1) SG11201903209TA (fr)
WO (1) WO2018071736A1 (fr)
ZA (1) ZA201902595B (fr)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK66202C (da) 1945-03-03 1948-01-12 Danske Securitas As Kodekontakt til elektriske Alarmanlæg.
DK71662C (da) 1946-09-05 1950-11-06 Ingenioer Frank Broadbent Tørrecentrifuge.
US4049813A (en) 1976-07-15 1977-09-20 Sandoz, Inc. Substituted isoxazolo pyridinones
US5837698A (en) * 1996-05-02 1998-11-17 G. D. Searle & Co. Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
JPWO2002102807A1 (ja) 2001-06-14 2004-09-30 萬有製薬株式会社 新規イソキサゾロピリドン誘導体及びその用途
GB0119911D0 (en) 2001-08-15 2001-10-10 Novartis Ag Organic Compounds
EP1691744A4 (fr) * 2003-11-13 2007-12-26 Combinatorx Inc Procedes et reactifs pour le traitement de troubles inflammatoires
AU2006286838C1 (en) * 2005-09-02 2013-05-02 Ferrer Internacional S.A. Nitrooxy derivatives of glucocorticoids
CN1813768A (zh) * 2005-11-18 2006-08-09 成都力思特制药股份有限公司 治疗呼吸系统疾病的药用组合物及其在制药中的应用
MX2010003698A (es) * 2007-10-04 2010-04-21 Astrazeneca Ab Compuestos de [3,2-c]pirazol esteroides con actividad glucocorticoide.
CA2707618A1 (fr) * 2007-12-20 2009-07-02 Astrazeneca Ab Derives de steroides agissant comme des agonistes des recepteurs de glucocorticosteroides
CA2749585A1 (fr) 2009-01-13 2010-07-22 Van Andel Research Institute Methodes d'utilisation de pyridinones isoxazolo-substituees en tant que glucocorticoides
UY32525A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32520A (es) 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides
UY32523A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
AR077101A1 (es) * 2009-06-16 2011-08-03 Schering Corp Esteroides de heteroarilo (3,2-c), como agonistas de receptor glucocorticoide, composiciones y usos de los mismos
AU2014324961A1 (en) * 2013-09-25 2016-04-14 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences Highly potent glucocorticoids
TWI695831B (zh) * 2014-09-13 2020-06-11 香港商南北兄弟藥業投資有限公司 Crth2拮抗劑化合物及其用途

Also Published As

Publication number Publication date
JP2019532071A (ja) 2019-11-07
WO2018071736A9 (fr) 2019-05-23
EP3525870B1 (fr) 2023-05-10
KR102497070B1 (ko) 2023-02-06
ZA201902595B (en) 2021-04-28
SG11201903209TA (en) 2019-05-30
JP7146750B2 (ja) 2022-10-04
ES2945983T3 (es) 2023-07-11
PH12019500801A1 (en) 2019-11-11
EP3525870A4 (fr) 2020-04-29
RU2019111101A3 (fr) 2020-11-27
CN110382033A (zh) 2019-10-25
KR20190068577A (ko) 2019-06-18
EP3525870A1 (fr) 2019-08-21
JP2022132464A (ja) 2022-09-08
RU2019111101A (ru) 2020-11-16
CN110382033B (zh) 2022-04-15
WO2018071736A1 (fr) 2018-04-19
US10954265B2 (en) 2021-03-23
US20190263853A1 (en) 2019-08-29

Similar Documents

Publication Publication Date Title
SG11202008388TA (en) Movement assistance device
IL260613B (en) Preparations for splicing DNA-binding domains and cleavage domains
SG10201701420WA (en) Inspection of Structures
DK3494116T3 (da) Østrogenreceptormodulatorer
HK1258910A1 (zh) 淋浴裝置
DK3569211T3 (da) Assistanceindretning
FR3055892B1 (fr) Materiau silicate de structure olivine
HK1254200A1 (zh) 氧肟酸三萜系化合物衍生物
ES1150811Y (es) Torniquete sanitario
PT3411535T (pt) Dispositivo de chuveiro
GB201609974D0 (en) Basin
DK3495571T3 (da) Bruseanordning
PL3555381T3 (pl) Lejek do instalacji sanitarnej
IT201600130386A1 (it) Dispositivo apriballe
MA46539A (fr) Structures et mécanisme pour la conception de glucocorticoïdes hautement puissants
GB2568065B (en) Plumbing device
ES1192458Y (es) Cespol para instalaciones de griferia
DE112017006237A5 (de) Wiedereinschaltgerät
ZAA201700355S (en) Circumcision assistance device
KR20180084938A (ko) 연속 주조 라인의 주조 장치 및 상기 주조 장치의 작동
ES1178760Y (es) Dispositivo de emergencia
FR3049751B1 (fr) Perfectionnement pour accordeon
FI11369U1 (fi) Luukku
IL265695A (en) Tests near the point of treatment
GB201917109D0 (en) Device for the determination of fertility status